Source: International Congress 2017 – Management of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Montuschi (Roma, Rm, Italy). NMR-based metabolomics of exhaled breath condensate for assessing the effects of inhaled corticosteroids in COPD patients. 3257

Member's Comments

No comment yet.

Related content which might interest you: Metabolomics applied to exhaled breath condensate in asthmatic children treated with inhaled steroids Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020 Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Metabonomics applied to exhaled breath condensate in childhood asthma Source: Eur Respir J 2006; 28: Suppl. 50, 123s Year: 2006 Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Il-6 levels in exhaled breath condensate (EBC) of children with moderate well-controlled asthma stepping down inhaled corticosteroids Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma Year: 2017 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Influence of oral steroid use in difficult-to-control asthma patients on metabolomic profile of oxidative stress in exhaled breath condensate (EXAIR project) Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study Source: Eur Respir J, 51 (3) 1701825; 10.1183/13993003.01825-2017 Year: 2018 Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006 Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Effects of inhaled corticosteroids on breath condensate inflammatory markers in childhood asthma Source: Eur Respir J 2005; 26: Suppl. 49, 41s Year: 2005 Cytokines in exhaled breath condensate of patients with asthma Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate Source: Eur Respir J 2006; 28: Suppl. 50, 747s Year: 2006 Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Acute effect of inhaled corticosteroid on exhaled breath temperature in asthmatic patients Source: Annual Congress 2012 - Exhaled biomarkers to assess airway inflammation Year: 2012 Exhaled breath condensate: metabolomics Source: Eur Respir Monogr 2010; 49: 231-236 Year: 2010 Targeted eicosanoid lipidomics of induced sputum as compared to exhaled breath condensate in asthmatics Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011